Avid Bioservices Inc reports results for the quarter ended in January - Earnings Summary

Avid Bioservices

13/03/2023 21:02

* Avid Bioservices Inc  CDMO.OQ  reported quarterly adjusted
earnings of 1 cent​​ per share for the quarter ended in January.
The mean expectation of four analysts for the quarter was for a
loss of 4 cents per share.
    * Revenue rose 20.7% to $38.02 million from a year ago;
analysts
expected $36.32 million. 
    * Avid Bioservices Inc's reported EPS for the quarter was 1
cent​.
    * The mean earnings estimate of analysts had fallen by
about 100%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Avid Bioservices Inc shares had risen by 1.3% this
quarter.
    * The company reported quarterly net income of $461
thousand.
    * Wall Street's median 12-month price target for Avid
Bioservices
Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 13 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 31 2023      -0.03          0.01           Beat
 Oct. 31 2022      0.00           -0.02          Missed
 Jul. 31 2022      0.04           0.02           Missed
 Apr. 30 2022      0.01           0.01           Met